Thursday, March 1, 2012

Clinical Trials

Clinical Trials

New Mandatory Language in Certain Informed Consent Documents

In accordance with Section 801 of the FDAAA, the informed consent regulations of 21 CFR 50.25 were amended to require informed consent documents and processes for applicable drug (including biologic products) and device clinical trials initiated on or after March 7, 2012. The following statement must be included, word-for-word:

"A description of this clinical trial will be available on, as required by U.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time."


Post a Comment

Subscribe to Post Comments [Atom]

<< Home